Dr. Sayed M. Yossef
Claim this profileCare Access - Youngstown
Studies Ulcer
Studies Ulcerative Colitis
4 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Sayed M. Yossef is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
Mirikizumab
for Ulcerative Colitis
This trial is testing mirikizumab, a medication for people with severe ulcerative colitis. It aims to see if the drug can reduce gut inflammation by blocking a protein that causes it. The study will last several years. Mirikizumab has shown positive results in early tests for ulcerative colitis.
Recruiting2 awards Phase 31 criteria
More about Sayed M. Yossef
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sayed M. Yossef has experience with
- Mirikizumab
- Donanemab
Breakdown of trials Sayed M. Yossef has run
Ulcerative Colitis
Inflammatory Bowel Disease
Crohn's Disease
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sayed M. Yossef specialize in?
Sayed M. Yossef focuses on Ulcer and Ulcerative Colitis. In particular, much of their work with Ulcer has involved treating patients, or patients who are undergoing treatment.
Is Sayed M. Yossef currently recruiting for clinical trials?
Yes, Sayed M. Yossef is currently recruiting for 2 clinical trials in Poland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Sayed M. Yossef has studied deeply?
Yes, Sayed M. Yossef has studied treatments such as Mirikizumab, Donanemab.
What is the best way to schedule an appointment with Sayed M. Yossef?
Apply for one of the trials that Sayed M. Yossef is conducting.
What is the office address of Sayed M. Yossef?
The office of Sayed M. Yossef is located at: Care Access - Youngstown, Poland, Ohio 44514 United States. This is the address for their practice at the Care Access - Youngstown.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.